<DOC>
	<DOCNO>NCT01165632</DOCNO>
	<brief_summary>RATIONALE : New image procedure , fluorine F 18 fluorodopa-labeled PET scan , may help guide surgery radiation therapy allow doctor plan good treatment . PURPOSE : This clinical trial study fluorine F 18 fluorodopa-labeled PET scan planning surgery radiation therapy treat patient newly diagnose high- low-grade malignant glioma</brief_summary>
	<brief_title>Fluorine F 18 Fluorodopa-Labeled PET Scan Planning Surgery Radiation Therapy Treating Patients With Newly Diagnosed High- Low-Grade Malignant Glioma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine correlation 18F-FDOPA PET activity , MRI contrast enhancement , high- low-grade glioma biopsy . II . To compare radiotherapy target volume delineation without 18F- FDOPA-PET metabolic image information determine role metabolic image radiotherapy treatment planning . SECONDARY OBJECTIVES : I . To determine correlation concordance 18F-FDOPA PET activity , MRI contrast enhancement , high- low-grade glioma biopsy patient outcomes include overall survival progression free survival . OUTLINE : Beginning 1 week biopsy resection , patient undergo fluorine F 18 fluorodopa-labeled PET/CT scan pre-operative MRI . Patients undergo stereotactic craniotomy . Some patient may also undergo radiation therapy . After completion study treatment , patient follow every year 5 year .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Gliosarcoma</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Glioma , Subependymal</mesh_term>
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Age â‰¥18 year . MRI finding compatible newly diagnose high lowgrade malignant glioma Planned craniotomy resection biopsy Willing sign release information radiation and/or followup record Negative pregnancy test do = &lt; 48 hour injection study drug , woman childbearing potential Provide inform write consent Patients eGFR &lt; 60 mg/min/1.72m2 eligible study ; PLEASE NOTE : patient eligible receive contrast pMRI study dose . Unable undergo MRI scan contrast ( e.g . cardiac pacemaker , defibrillator , kidney failure ) Unable undergo 18FFDOPA PET scan ( e.g . Parkinson 's Disease , take antidopaminergic , dopamine agonist medication le 6 halflives discontinuance dopamine agonist ) Pregnant woman ; nurse woman ; men woman childbearing potential unwilling employ adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>